Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://maeqtge480377.wikicorrespondent.com/7463299/this_new_drug_retatrutide_australia_a_promising_breakthrough_for_losing_weight